Ischemia-Modified Albumin (IMA) levels in ectopic pregnancy and early pregnancy loss.
Early pregnancy loss
IMA
ectopic pregnancy
Journal
Nigerian journal of clinical practice
ISSN: 1119-3077
Titre abrégé: Niger J Clin Pract
Pays: India
ID NLM: 101150032
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
23
7
2022
Statut:
ppublish
Résumé
IMA is a novel marker to consider in ischemic conditions. The initial stages of pregnancy represent a physiological ischemic status. IMA levels may be changed when there is suspicion of early pregnancy complications because of increased oxidative stress. We aimed to determine and compare IMA values in cases of ectopic and healthy pregnancies as well as early pregnancy loss. This prospective case control study population (n = 91) consisted of early pregnancy loss (n = 28), ectopic pregnancy (n = 28), and an intracavitary early healthy pregnancy (n = 35). The serum IMA levels were compared in these groups. Demographic parameters were similar and there was no significant difference between the three groups in terms of serum IMA concentrations. We suggested that IMA cannot be used clinically for the diagnosis and follow up of early pregnancy complications during the first five to six gestational weeks.
Sections du résumé
Background
UNASSIGNED
IMA is a novel marker to consider in ischemic conditions. The initial stages of pregnancy represent a physiological ischemic status. IMA levels may be changed when there is suspicion of early pregnancy complications because of increased oxidative stress.
Aim
UNASSIGNED
We aimed to determine and compare IMA values in cases of ectopic and healthy pregnancies as well as early pregnancy loss.
Methods
UNASSIGNED
This prospective case control study population (n = 91) consisted of early pregnancy loss (n = 28), ectopic pregnancy (n = 28), and an intracavitary early healthy pregnancy (n = 35). The serum IMA levels were compared in these groups.
Results
UNASSIGNED
Demographic parameters were similar and there was no significant difference between the three groups in terms of serum IMA concentrations.
Conclusion
UNASSIGNED
We suggested that IMA cannot be used clinically for the diagnosis and follow up of early pregnancy complications during the first five to six gestational weeks.
Identifiants
pubmed: 35859454
pii: NigerJClinPract_2022_25_7_975_351444
doi: 10.4103/njcp.njcp_1464_21
doi:
Substances chimiques
Biomarkers
0
Serum Albumin
0
ischemia-modified albumin
0
Serum Albumin, Human
ZIF514RVZR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
975-978Déclaration de conflit d'intérêts
None